Regression of a melanoma brain metastasis that had appeared after immune checkpoint inhibitor discontinuation: a hypothesis-generating case-Reference-Cited by-同舟云学术

Regression of a melanoma brain metastasis that had appeared after immune checkpoint inhibitor discontinuation: a hypothesis-generating case

Published:2023-07-19 Issue: Volume: Page:1-5
ISSN:1784-3286
Container-title:Acta Clinica Belgica
language:en
Short-container-title:Acta Clinica Belgica

Author:

Pierrard Julien¹²^ORCID,Seront Emmanuel³⁴^ORCID,Galot Rachel¹³^ORCID,Gunes Tatar Idil⁵,Baurain Jean-François¹³^ORCID,Di Perri Dario²^ORCID

Affiliation:

1. UCLouvain, Institut de Recherche Experimentale Et Clinique (IREC), Center of Molecular Imaging, Radiotherapy and Oncology (MIRO), Brussels, Belgium

2. Radiation Oncology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium

3. Medical Oncology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium

4. Medical Oncology Department, Hopital de Jolimont, Haine Saint Paul, Belgium

5. Radiology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium

Funder

Fonds De La Recherche Scientifique – FNRS

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17843286.2023.2238374

Reference31 articles.

1. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

2. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

3. Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo

4. Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study

5. RECIST 1.1—Update and clarification: From the RECIST committee

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2024-01-27